Sareri MI

No ORCID on file · 2 papers in corpus

letter 2025

Reply to 'Critical appraisal of "Comparison of combined oral contraceptives and dienogest for endometriosis-associated pain"'

European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113945

preprint 2022

Randomized Study on the Effectiveness of Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive vs Dienogest Oral Pill in Women with Endometriosis‑Associated Chronic Pelvic Pain

·doi:10.21203/rs.3.rs-1323526/v1

Abstract Background: To evaluate the effects of a combined oral contraceptive containing 1.5mg 17b-estradiol (E2) and 2.5mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic …